← Back to Search

Time Restricted Eating for Obesity

N/A
Waitlist Available
Led By Bradley Bohn, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial looks at the effects of when you eat on weight and BMI, and how it affects quality of life.

Who is the study for?
This trial is for obese adults with a BMI of 25 or higher who are willing to limit their eating to an 8-hour window. It's not suitable for those with cancer, pregnant or breastfeeding women, individuals who regularly skip meals, those on certain diabetes or weight loss medications, and people with a history of eating disorders.
What is being tested?
The study is examining the effects of early versus late time-restricted eating on weight and BMI in obese adults. Participants will be asked to eat only during an 8-hour period each day to see how this impacts their health and quality of life.
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include hunger outside the eating window, potential changes in energy levels, mood swings due to hunger pangs, and possible alterations in social meal times.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in weight
Secondary study objectives
Change in Hemoglobin A1c
Change in High-density lipoprotein (HDL) cholesterol
Change in Low-density lipoprotein (LDL) cholesterol
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Late time-restricted eatingExperimental Treatment1 Intervention
Subjects window for eating would be between 12:00 PM (noon) and 8:00 PM
Group II: Early time-restricted eatingExperimental Treatment1 Intervention
Subjects window for eating would be between 08:00 AM - 4:00 PM
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Late time-restricted eating
2022
N/A
~200
Early time-restricted eating
2022
N/A
~200

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,326 Previous Clinical Trials
3,059,394 Total Patients Enrolled
88 Trials studying Obesity
9,137 Patients Enrolled for Obesity
Bradley Bohn, MDPrincipal InvestigatorMayo Clinic

Media Library

Early time-restricted eating Clinical Trial Eligibility Overview. Trial Name: NCT05660291 — N/A
Obesity Research Study Groups: Late time-restricted eating, Early time-restricted eating
Obesity Clinical Trial 2023: Early time-restricted eating Highlights & Side Effects. Trial Name: NCT05660291 — N/A
Early time-restricted eating 2023 Treatment Timeline for Medical Study. Trial Name: NCT05660291 — N/A
~0 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top